openPR Logo
Press release

Cytomegalovirus Infection Market: Key Players and Production Information Analysis 2017 - 2025

02-15-2018 01:52 PM CET | Health & Medicine

Press release from: Persistence Market Research

Cytomegalovirus Infection Market: Key Players and Production

Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/17356

The infection can be diagnosed through serological testing methods such as Enzyme-linked immunoassay test.  Many of the cases of CMV goes undiagnosed in early stage of infection thus the awareness about the infection is most important factor. According to the Centers for Disease Control and Prevention (CDC), in U.S., each year around 150 infants are born with cytomegalovirus infections and few of them have long term health problems.  

The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.

Based on product type, the market is segmented into Cidofovir, Foscarnet,  Valganciclovir, and Ganciclovir. These are few of the most prescriobed medication for the treatment of cytomegalovirus. Similarly, based on distribution channel, the market is segmented into, hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies are expected to hold maximum share in the market due to the easy availability of medication and increasing prescription patterns for the treatment of CMV.

Region wise, the global cytomegalovirus infection market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. The growth of CMV virus is attributed to the increasing awareness regarding the herpes virus and increasing diagnosis rate in developed region such as North America and Europe.  Similarly, the government initiatives for the awareness regarding rate disease, growing healthcare expenditure and escalating disposable income are few of the factors responsible the market growth in Asia-Pacific.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/17356

The key players in the market are F. Hoffmann-La Roche, GlaxoSmithKline plc, Vical, Inc., AiCuris Anti-infective Cures GmbH, ViroPharma, Chimerix, Inc., and others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus Infection Market: Key Players and Production Information Analysis 2017 - 2025 here

News-ID: 945249 • Views:

More Releases from Persistence Market Research

Roasted Corn Market to Reach $5.5B by 2033 Driven by Rising Snack Demand
Roasted Corn Market to Reach $5.5B by 2033 Driven by Rising Snack Demand
The global roasted corn market is poised for steady expansion, driven by rising consumer preference for convenient, ready-to-eat snacks and increasing awareness of healthier alternatives to traditional fried snack options. Current market estimates indicate that the roasted corn market is valued at approximately US$ 3.8 billion in 2026 and is projected to reach US$ 5.5 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.4% between 2026 and
Food Emulsifier Market to Reach $5.3B by 2033 Driven by Rising Processed Foods
Food Emulsifier Market to Reach $5.3B by 2033 Driven by Rising Processed Foods
The global food emulsifier market is set for steady growth over the coming decade, driven by increasing demand for processed and convenience foods, functional ingredients, and enhanced food quality across the food and beverage industry. The market is estimated to be valued at approximately US$ 3.9 billion in 2026 and is projected to reach US$ 5.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.6% from 2026
Seaweed Derivatives Market to Reach $2.5B by 2033, Driven by Rising Demand
Seaweed Derivatives Market to Reach $2.5B by 2033, Driven by Rising Demand
The global seaweed derivatives market is experiencing steady growth, driven by increasing demand across food, pharmaceuticals, cosmetics, agriculture, and industrial applications. Current market estimates indicate that the seaweed derivatives market is valued at approximately US$ 1.8 billion in 2026 and is projected to reach US$ 2.5 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2026 to 2033. This growth underscores the
Track Geometry Measurement System Market to Reach US$ 5,825 Million by 2032 at 5.1% CAGR | Persistence Market Research Outlook
Track Geometry Measurement System Market to Reach US$ 5,825 Million by 2032 at 5 …
The Track Geometry Measurement System Market is gaining strong momentum as railway networks worldwide prioritize safety, efficiency, and predictive maintenance. These systems are designed to measure track parameters such as alignment, curvature, cross-level, and gauge, ensuring safe train operations. With increasing investments in railway infrastructure, metro rail projects, and high-speed rail networks, the demand for advanced track inspection solutions continues to grow. Modern track geometry measurement systems are equipped with

All 5 Releases


More Releases for CMV

Cytomegalovirus (CMV) Infections Market Massive Growth opportunity Ahead
Introduction Cytomegalovirus (CMV) is a common herpesvirus that affects people worldwide, often remaining latent in the body and reactivating under immunocompromised conditions. While typically asymptomatic in healthy individuals, CMV can cause severe complications in newborns, transplant recipients, and immunocompromised patients, making it a significant global healthcare burden. With increasing awareness, advances in antiviral therapies, vaccines under development, and transplant-related CMV management, the CMV infections market is experiencing strong growth. The integration of
Cytomegalovirus (CMV) Vaccine Market | Exploring Current Trends and Growth Statu …
Cytomegalovirus (CMV) Vaccine Market Outlook and Investment Analysis What is the current outlook for the Cytomegalovirus (CMV) vaccine market? The CMV vaccine market is seeing positive growth due to the increasing prevalence of CMV infections globally, particularly in immunocompromised populations such as organ transplant recipients and HIV patients. Moreover, the growing awareness of CMV's impact on newborns has contributed to the push for preventive vaccines. A few vaccines are in advanced clinical
Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Global Commercial Cooking Device Market Forecast 2018-2025 CMV Sharper Finish, Q …
Market study on Global Commercial Cooking Device 2018 Research Report presents a professional and complete analysis of Global Commercial Cooking Device Market on the current market situation. Report provides a general overview of the Commercial Cooking Device industry 2018 including definitions, classifications, Commercial Cooking Device market analysis, a wide range of applications and Commercial Cooking Device industry chain structure. The 2018's report on Commercial Cooking Device industry offers the global
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can